Guangdong Tapai Group (002233.SZ) stated on the investor platform that its main business is the research and development, production, and sales of functional probiotic products. As a beneficial microorganism to the human body, functional probiotics have attracted widespread attention in the health industry in recent years, and the company is bullish on the market prospects in this field. The company plans to cooperate with competitive research institutions in the industry to provide high-quality functional probiotic products to consumers. Currently, the team is being built, and pre-sales before product launch are being prepared. Subsequently, the promotion and sales of product categories will gradually expand and strive to create a second growth curve. If the project meets the disclosure requirements, the company will timely fulfill its information disclosure obligations in accordance with regulations.
塔牌集团(002233.SZ)：塔牌生物主营功能性益生菌产品的研发与生产、销售等业务
Guangdong Tapai Group (002233.SZ): The main business of Tapai Biology is the research and development, production, sales, and other business of functional probiotic products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.